Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1650 USD | -11.58% |
|
-96.84% | -97.24% |
02-06 | BioXcel to Implement Reverse Stock Split; Shares Fall | MT |
02-05 | BioXcel Therapeutics Provides Clinical and Business Update | RE |
Evolution of the Average Target: BioXcel Therapeutics
Evolution of the Target Price: BioXcel Therapeutics
Changes in Analyst Recommendations: BioXcel Therapeutics
Analysts' Consensus

Analyst Consensus Detail
Consensus revision (last 18 months)
Analysts covering the company
BofA Securities | |
Canaccord Genuity | |
UBS | |
Truist Securities | |
HC Wainwright | |
Goldman Sachs | |
Mizuho Securities | |
Guggenheim | |
Jefferies & Co. | |
Berenberg Bank |
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- BTAI Stock
- Consensus BioXcel Therapeutics

MarketScreener is also available in this country: United States.
Switch edition